Dolat Capital: Sun Pharma Q2 Review - Operational Beat, Sustenance Of Specialty Business Growth Key
Medicinal tablets are arranged for a photograph in Mumbai. (Photographer: Dhiraj Singh/Bloombergg)

Dolat Capital: Sun Pharma Q2 Review - Operational Beat, Sustenance Of Specialty Business Growth Key

Bookmark
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer Bl...